Pittsburgh-based Medical RFID Industries develops patented DNA specimen collection devices and real-time systems for capturing and preserving genetic samples. Its projects include the IDmarx global DNA network, alongside software and satellite data-network development intended to move DNA analysis closer to the collection site.
Mobile AspectsMobile Aspects develops healthcare software and IoT hardware for hospital operations, including RFID-enabled tracking equipment. Founded by engineers with backgrounds at Johns Hopkins, the University of Pennsylvania, and Westinghouse, the Pittsburgh-based company has worked with hospitals for more than 25 years and reports over 500 implementations. Its offerings support hospital supply-chain, endoscopy, and biologics workflows.PITTSBURGH, PA
Novel Microdevices, IncBaltimore-based Novel Microdevices develops portable, sample-to-answer molecular diagnostic systems built around disposable microfluidic cartridges. Its battery-powered Novel Dx platform is designed to deliver lab-quality PCR results in about 15 minutes, including testing for respiratory infections and other diseases at the point of care. The company is establishing a GMP-compliant pilot manufacturing facility at its Baltimore headquarters to scale cartridge production.BALTIMORE, MD
HI-TECH Business Systems, Inc. dba HI-TECH RFIDIncorporated in Maryland in 1987, HI-TECH Business Systems—doing business as HI-TECH RFID—builds and integrates RFID inventory and asset-tracking systems for military, government, healthcare, and university operations. Its distinctive specialty is secure RFID for sensitive environments, including custom crypto tags designed to prevent cloning and unauthorized reading, with a mechanical switch-off mode that eliminates the tag’s electronic signature. Led by president and founder Bryan T. Meehan Sr., the company says it has installed and integrated systems in more than 3,000 organizations.PERRY HALL, MD
TrimGen CorporationFounded in 1999, Sparks-based TrimGen Corporation develops genetic testing products and proprietary molecular technologies for clinical research and early disease detection. Its work includes the patented Shifted Termination Assay for sensitive mutation analysis and WaxFree extraction technology, which is designed to recover nucleic acids from limited FFPE and FNA tissue. TrimGen says its products are used by clinical laboratories globally and have been cited in hundreds of academic publications.SPARKS GLENCOE, MD